PDS Biotechnology Corp Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PDS Biotechnology Corp (PDSB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$89.28 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-03
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$89.28K.
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$347.30K.
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$144.09K.
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$118.03K.
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$686.71K.
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.31M.
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$884.79K.
- PDS Biotechnology Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$136.89K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$89.28K 10-Q · filed 2017-05-03 | -$436.58K derived: sum of 2 quarters · filed 2017-05-03 | -$580.67K derived: sum of 3 quarters · filed 2017-05-03 | -$698.70K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | -$347.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$491.39K derived: sum of 2 quarters · filed 2017-03-02 | -$609.42K derived: sum of 3 quarters · filed 2017-03-02 | -$686.71K 10-K · filed 2017-03-02 |
| 2016-09-30 | -$144.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$262.12K derived: sum of 2 quarters · filed 2016-11-01 | -$339.41K 10-Q · filed 2016-11-01 | -$845.07K derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-06-30 | -$118.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$195.32K 10-Q · filed 2016-08-03 | -$700.98K derived: sum of 3 quarters · filed 2017-05-03 | -$1.05M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-03-31 | -$77.29K 10-Q · filed 2017-05-03 | -$582.95K derived: sum of 2 quarters · filed 2017-05-03 | -$935.20K derived: sum of 3 quarters · filed 2017-05-03 | -$1.30M derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | -$505.66K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$857.92K derived: sum of 2 quarters · filed 2017-03-02 | -$1.22M derived: sum of 3 quarters · filed 2017-03-02 | -$1.31M 10-K · filed 2017-03-02 |
| 2015-09-30 | -$352.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$713.35K derived: sum of 2 quarters · filed 2016-11-01 | -$799.42K 10-Q · filed 2016-11-01 | -$1.42M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | -$361.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$447.17K 10-Q · filed 2016-08-03 | -$1.07M derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | -$86.08K 10-Q · filed 2016-05-03 | -$705.72K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | -$619.64K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$884.79K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | -$265.15K 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | -$136.89K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |